drugset / Trial / NCT02543658

Neostigmine Treatment of Acute Pancreatitis Combined With Intra-abdominal Hypertension

NCT02543658

RandomizedParallel-groupSingle-blindTreatment

Summary

Acute pancreatitis(A) often complicated with Intra-abdominal Hypertension. After the onset of acute pancreatitis, capillary leakage causing ascites,upper gastrointestinal tract obstruction and paralytic ileus leading to an elevated IAP, severe IAH leads to ACS with high mortality. Neostigmine is an anti-cholinesterase drugs, can enhance intestinal peristalsis, promote flatus defecation. The aim of this study was to determine the effect of neostigmine on reducing abdominal pressure and clinical prognosis in patients with AP by promoting intestinal peristalsis and defecation.

Timeline

Start
2015-09-01
Primary completion
2017-08-15
Completion
2018-05-30

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Neostigmine Other / unclassified 1 mg

Indications